US exempts India and 19 nations from 100% tariff on certain speciality drugs: Report

The US has announced it will exempt certain speciality drugs and ingredients imported from India and 19 other countries from 100% tariffs. This decision is a significant relief for pharmaceutical companies in these countries, as it will allow them to export their products to the US without incurring additional costs. The exemption applies to drugs intended for rare diseases and infertility, along with their components, and is part of a broader effort to ease trade tensions and promote economic cooperation.

Why it matters

The US exemption of certain speciality drugs from tariffs will benefit India's pharmaceutical industry. Indian companies can increase their exports to the US without facing high tariffs.

Market impact

Markets & countries in focus

Transmission channels

Likely winners & losers

Explore the intelligence

MeridStreet does not reproduce source articles. The summary and analysis above are generated by MeridStreet from public headlines and its own market model; the original reporting belongs to Economic Times. For information only — not financial advice.